摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1S,2R)-1-methyl-1,2-cyclopropanedicarboxylic acid | 148261-89-6

中文名称
——
中文别名
——
英文名称
(1S,2R)-1-methyl-1,2-cyclopropanedicarboxylic acid
英文别名
(1S,2R)-1-methylcyclopropane-1,2-dicarboxylic acid
(1S,2R)-1-methyl-1,2-cyclopropanedicarboxylic acid化学式
CAS
148261-89-6
化学式
C6H8O4
mdl
——
分子量
144.127
InChiKey
CUXGZYHWQYTLKE-DZSWIPIPSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.2
  • 重原子数:
    10
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    74.6
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (1S,2R)-1-methyl-1,2-cyclopropanedicarboxylic acid乙酰氯 作用下, 反应 0.5h, 以1.25 g的产率得到(1S,2R)-1-methyl-1,2-cyclopropanedicarboxylic anhydride
    参考文献:
    名称:
    Chiroptical properties of 1,2-cyclopropanedicarboxylic anhydrides and imides. The cyclopropane ring contribution to the Cotton effect
    摘要:
    Several optically active 1,2-cyclopropanedicarboxylic anhydrides and imides were prepared and their chiroptical spectra studied. Despite the strained bicyclic skeleton of these compounds, their CD spectra show an unusual solvent dependence. This phenomenon can be explained in terms of the cyclopropane ring contribution to the Cotton effect. A deviation of the skeleton and the anhydride or imide group from the local C(s) symmetry, shown by MNDO calculations, causes formation of an inherently chiral chromophore constituted by the three-membered ring and neighboring carbonyls. This kind of chromophore is responsible for the observed strong Cotton effects.
    DOI:
    10.1021/jo00064a034
  • 作为产物:
    描述:
    2,4-dimethylpentan-3-yl (1S,2S)-2-methyl-2-phenylcyclopropane-1-carboxylate 在 ruthenium trichloride 、 氢氧化钾sodium periodate 作用下, 以 甲醇乙腈 为溶剂, 生成 (1S,2R)-1-methyl-1,2-cyclopropanedicarboxylic acid
    参考文献:
    名称:
    Highly Enantioselective Intermolecular Cyclopropanation Catalyzed by Dirhodium(II) Tetrakis[3(S)-phthalimido-2-piperidinonate]: Solvent Dependency of the Enantioselection
    摘要:
    由二铑(II)四[3(S)-邻苯二甲酰胺-2-哌啶酸酯]催化的环丙烷化反应中的对映选择性已被发现通过使用作为罕见溶剂的醚显著改善。该催化剂促进了苯乙烯或1,1-二取代烯烃与2,4-二甲基-3-戊基二氮酰乙酸酯在醚中进行的环丙烷化反应,产生了相应的环丙烷产品,报告的对映选择性达到最高水平(高达98% ee),这是迄今为止二铑(II)催化的分子间环丙烷化反应中所取得的最高记录。
    DOI:
    10.1055/s-1997-994
点击查看最新优质反应信息

文献信息

  • Dicarboxamide derivatives
    申请人:F. HOFFMANN-LA ROCHE AG
    公开号:EP1847537A1
    公开(公告)日:2007-10-24
    The invention is concerned with dicarboxamide derivatives of formula (I) wherein R1, R2, R3, R4, R5 and R6 are as defined in the specification, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments.
    这项发明涉及公式(I)的二羧酰胺衍生物,其中R1,R2,R3,R4,R5和R6如规范中所定义,以及其生理上可接受的盐。这些化合物抑制凝血因子Xa,可用作药物。
  • Dicarboxamide Derivatives
    申请人:Zbinden Katrin Groebke
    公开号:US20110195997A1
    公开(公告)日:2011-08-11
    The invention is concerned with dicarboxamide derivatives of formula (I) wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are as defined in the specification, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used in pharmaceutical compositions.
    本发明涉及公式(I)的二羧酰胺衍生物,其中R1,R2,R3,R4,R5和R6如规范中所定义,以及其生理上可接受的盐。这些化合物抑制凝血因子Xa并可用于制备药物组合物。
  • [EN] DICARBOXAMIDE DERIVATIVES<br/>[FR] DERIVES DU DICARBOXAMIDE
    申请人:HOFFMANN LA ROCHE
    公开号:WO2007122104A1
    公开(公告)日:2007-11-01
    [EN] The invention is concerned with dicarboxamide derivatives of formula (I) wherein R1, R2, R3, R4, R5 and R6 are as defined in the specification, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments.
    [FR] La présente invention concerne des dérivés du dicarboxamide de formule (I) dans laquelle R1, R2, R3, R4, R5 et R6 sont tels que définis dans le mémoire descriptif. L'invention concerne également les sels physiologiquement acceptables desdits dérivés. Ces composés inhibent le facteur de coagulation Xa et ils peuvent être utilisés en tant que médicaments.
  • Chiroptical properties of 1,2-cyclopropanedicarboxylic anhydrides and imides. The cyclopropane ring contribution to the Cotton effect
    作者:Tadeusz Polonski、Maria J. Milewska、Andrzej Katrusiak
    DOI:10.1021/jo00064a034
    日期:1993.6
    Several optically active 1,2-cyclopropanedicarboxylic anhydrides and imides were prepared and their chiroptical spectra studied. Despite the strained bicyclic skeleton of these compounds, their CD spectra show an unusual solvent dependence. This phenomenon can be explained in terms of the cyclopropane ring contribution to the Cotton effect. A deviation of the skeleton and the anhydride or imide group from the local C(s) symmetry, shown by MNDO calculations, causes formation of an inherently chiral chromophore constituted by the three-membered ring and neighboring carbonyls. This kind of chromophore is responsible for the observed strong Cotton effects.
  • Highly Enantioselective Intermolecular Cyclopropanation Catalyzed by Dirhodium(II) Tetrakis[3(<i>S</i>)-phthalimido-2-piperidinonate]: Solvent Dependency of the Enantioselection
    作者:Shinji Kitagaki、Hideo Matsuda、Nobuhide Watanabe、Shun-ichi Hashimoto
    DOI:10.1055/s-1997-994
    日期:1997.10
    The enantioselectivity in cyclopropanations catalyzed by dirhodium(II) tetrakis[3(S)-phthalimido-2-piperidinonate] has been found to be substantially improved by employing ether as the rarely used solvent. Cyclopropanations of styrenes or 1,1-disubstituted alkenes with 2,4-dimethyl-3-pentyl diazoacetate in ether are promoted by this catalyst to afford the corresponding cyclopropane products in the highest levels of enantioselectivity (up to 98% ee) reported to date for the dirhodium(II)-catalyzed intermolecular cyclopropanation reactions.
    由二铑(II)四[3(S)-邻苯二甲酰胺-2-哌啶酸酯]催化的环丙烷化反应中的对映选择性已被发现通过使用作为罕见溶剂的醚显著改善。该催化剂促进了苯乙烯或1,1-二取代烯烃与2,4-二甲基-3-戊基二氮酰乙酸酯在醚中进行的环丙烷化反应,产生了相应的环丙烷产品,报告的对映选择性达到最高水平(高达98% ee),这是迄今为止二铑(II)催化的分子间环丙烷化反应中所取得的最高记录。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物